Market Capitalization (Millions $) |
- |
Shares
Outstanding (Millions) |
- |
Employees |
4,045 |
Revenues (TTM) (Millions $) |
1,106 |
Net Income (TTM) (Millions $) |
58 |
Cash Flow (TTM) (Millions $) |
-25 |
Capital Exp. (TTM) (Millions $) |
13 |
Embecta Corp
The company is a global medical device company that focuses on providing solutions to improve the health and well-being of people living with diabetes. Their products are used by nearly 30 million people in over 100 countries for insulin administration and to aid with the daily management of diabetes. The company has a broad portfolio of marketed products, including a variety of pen needles, syringes, and safety injection devices. The company also seeks to promote advances in diabetes care through thought leadership and engagement with the diabetes community. They have three manufacturing sites located in Ireland, the United States, and China, and they distribute their products through a variety of channels, including retail, hospitals, pharmacies, and other institutional channels. The company uses a combination of patents, copyrights, trademarks, trade secrets, nondisclosure agreements, and other measures to establish and protect their proprietary rights.
In summary, the company is a leading global medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. With close to 100 years of experience in the industry, the company has become one of the most widely recognized and respected brands in diabetes management in the world.
The company's broad portfolio of products, including pen needles, syringes, and safety injection devices, as well as its proprietary digital application designed to assist people with managing their diabetes, has made a significant impact in diabetes care. The company's commitment to research and development, coupled with its global operations and strong financial performance, positions it for continued growth and success in the future.
Company Address: 300 Kimball Drive, Suite 300 Parsippany 7054 NJ
Company Phone Number: 401-0000 Stock Exchange / Ticker: NASDAQ EMBC
|